Plain English Summary
Background and study aims
There is a lack of evidence regarding the impact of cigarette pack sizes (the number of cigarettes per pack) on the number of cigarettes people smoke. The aim of this study is to estimate the impact of asking smokers to buy cigarettes in smaller pack sizes on how many cigarettes they smoke. The results of this study will contribute to policy questions on whether cigarette pack sizes should be capped at 20 cigarettes per pack.
Who can participate?
Adult smokers living in Australia who currently smoke an eligible brand-variant of factory-made cigarettes from pack sizes of 25 cigarettes or more are eligible to participate in this study.
What does the study involve?
Participants will be randomly allocated to either the control or the intervention condition. Participants in the intervention condition will be asked to purchase their usual brand variant of cigarettes in pack sizes of 20 for four weeks. Participants in the control condition will be asked to continue purchasing cigarettes in their normal pack sizes.
What are the possible benefits and risks of participating?
Participants will be helping to further our understanding of the effect of cigarette pack sizes on smoking. A summary of the research findings will be made available to participants.
Participants receive online vouchers in compensation for their time spent completing the study.
Where is the study run from?
Roy Morgan Research Ltd, Tonic House, 386 Flinders Lane, Melbourne, Australia, VIC 3000
When is the study starting and how long is it expected to run for?
The study started in September 2018 and is expected to run for nine months until June 2019.
Who is funding the study?
The study is funded by the Collaborative Award in Science from Wellcome Trust (Behaviour Change by Design: 206853/Z/17/Z) awarded to Theresa Marteau, Paul Fletcher, Gareth Hollands and Marcus Munafò. The funder is not involved in the study design or data analysis.
Who is the main contact?
Professor Theresa Marteau, Director of the Behaviour and Health Research Unit, University of Cambridge, tm388@medschl.cam.ac.uk.
Trial website
Contact information
Type
Scientific
Primary contact
Prof Theresa Marteau
ORCID ID
http://orcid.org/0000-0003-3025-1129
Contact details
Institute of Public Health
Forvie Site
Robinson Way
Cambridge
CB2 0SR
Cambridge
NN15 7NH
United Kingdom
Type
Public
Additional contact
Prof Theresa Marteau
ORCID ID
http://orcid.org/0000-0003-3025-1129
Contact details
Institute of Public Health
Forvie Site
Robinson Way
Cambridge
CB2 0SR
Cambridge
CB2 0SR
United Kingdom
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
Cigarette pack size and consumption: a parallel group randomised controlled trial
Study information
Scientific title
Cigarette pack size and consumption: a parallel group randomised controlled trial
Acronym
Study hypothesis
Participants smoking from pack sizes of 20 cigarettes will smoke fewer cigarettes than those smoking from pack sizes of 25 cigarettes or more.
Ethics approval
Cambridge Psychology Research Ethics Committee, 13/09/2018, ref. PRE.2018.037.
Amendments made to protocol in December 2018, ref. PRE.2018.125 - approval pending
Study design
Interventional, parallel group, randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Home
Trial type
Prevention
Patient information sheet
See additional files
Condition
Tobacco use
Intervention
A randomised controlled trial in which smokers who routinely purchase cigarettes in pack sizes of 25 or more are randomised to one of two groups for a period of 4 weeks:
Group 1: Intervention: buy usual brand variant of cigarettes in single pack sizes of 20
Group 2: Control: buy usual brand of cigarettes in usual pack size
Participants will not be informed of the true aim of the study.
Participants will be recruited through a research agency, Roy Morgan Research Ltd from across Australia.
Participants in the intervention group will be asked to buy their usual brand variant of cigarettes in single pack sizes of 20 cigarettes per pack for a period of four weeks. Participants in the control condition will be asked to continue to purchase their usual brand of cigarettes in the usual pack size (25 cigarettes or greater) for four weeks.
Once participants have successfully completed a baseline week in which they return receipts for any cigarette packs purchased that week they are randomly allocated. Allocation of participants to purchase cigarettes in pack sizes of 20 or their usual size of pack will be determined using a computer-generated random number sequence prepared by the senior project statistician.
Intervention type
Behavioural
Phase
Drug names
Primary outcome measure
The primary outcome measure is the number of cigarettes smoked by participants in a four-week period.
The primary outcome measure will be assessed from empty cigarette packs returned each week for four weeks, with a sticker on each pack completed by the participant stating:
1. Date pack started
2. Date pack finished
3. Number of cigarettes smoked from this pack
4. Number of cigarettes smoked by someone else from this pack
5. Number of cigarettes smoked from someone else’s pack during these dates
6. Rating of warning message (to fit with cover story)
Secondary outcome measures
Three secondary outcome measures will be taken at the point of recruitment via telephone and two weeks after completing procedures required for the primary endpoint (returning four weeks of empty cigarette packs) either by telephone or via an online survey.
1. Nicotine dependence will be measured by the Heaviness of Smoking Index (HSI)
2. Participants’ motivation to stop smoking will be measured by the Motivation to Stop Smoking scale (MTSS)
3. Participants’ autonomy over their smoking behaviour will be measured by the Autonomy Over Smoking Scale (AUTOS)
Overall trial start date
01/02/2018
Overall trial end date
21/01/2019
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
1. Aged 18 and over.
2. Smoke factory made cigarettes.
3. Smoke 5 or more cigarettes a day on every day of the week.
4. Smoked at least 100 cigarettes in his or her lifetime.
5. Routinely purchase cigarettes in packs of 25 or more.
6. Use a brand or brand variant in which cigarettes are available in pack sizes of 20 as well as sizes of one or more of the following: 25, 26, 30, 35, 40, 43 and/or 50.
7. Use a brand variant that is stocked in a pack size of 20 by at least one of the two major Australian supermarkets in the month before recruitment.
8. Live anywhere in Australia.
9. Able to read and write sufficient English to complete all study procedures.
10. Willing to collect and post one week of receipts of cigarettes purchased at baseline.
11. Willing to record on each cigarette pack dates when the pack was opened and when finished.
12. Willing to post weekly envelopes – on four consecutive weeks - containing all empty packs of cigarettes smoked in the preceding week with completed forms.
13. Willing to undergo a telephone interview at the end of the study.
Participant type
Healthy volunteer
Age group
Adult
Gender
Both
Target number of participants
250
Total final enrolment
187
Participant exclusion criteria
1. Pregnant women.
2. Intend to quit smoking in the next three months.
3. Used e-cigarettes weekly over the past month, and intend to continue.
4. Smoked roll-your-own (RYO) cigarettes once a week or more over the past month and intend to continue.
5. Normally transfer cigarettes into a case.
6. Don’t usually buy their own cigarettes.
7. Live in the same household as someone who has enrolled in the study.
8. Do not own a mobile phone or similar device with the ability to send photos via a text or email message.
9. Purchase their cigarettes with the intention of sharing half or more of them with another person.
Recruitment start date
01/09/2018
Recruitment end date
03/11/2018
Locations
Countries of recruitment
Australia
Trial participating centre
Roy Morgan Research Ltd
Tonic House, 386 Flinders Lane, Melbourne, Australia, VIC 3000
Melbourne
VIC 3000
Australia
Funders
Funder type
Research organisation
Funder name
Wellcome Trust
Alternative name(s)
Wellcome
Funding Body Type
private sector organisation
Funding Body Subtype
international
Location
United Kingdom
Results and Publications
Publication and dissemination plan
The findings from this study will be published in at least one scientific journal in 2020 and made available open access. They will also be presented at one or more scientific meetings.
IPD sharing statement: the data will be made available for sharing via the University of Cambridge Research Data Repository or Open Science Framework online data repository once the findings have been published.
Intention to publish date
01/06/2020
Participant level data
Stored in repository
Basic results (scientific)
Publication list
Publication citations
Additional files
- ISRCTN34202533_PIS_V4.pdf Uploaded 04/01/2019